Skip to Content
Merck
  • miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.

miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.

FEBS letters (2015-01-03)
Xinyun Xu, Weijun Wang, Ning Su, Xujun Zhu, Jun Yao, Wenchao Gao, Zhiqian Hu, Yanping Sun
ABSTRACT

MicroRNAs (miRNAs) play a prominent role in gastric cancer (GC) initiation and progression. In this study, we found that miR-374a expression was up-regulated in human GC cell lines and tissues. Inhibition of miR-374a suppressed GC cell proliferation, migration and invasion in vitro and slowed tumor growth in vivo. SRC kinase signaling inhibitor 1 (SRCIN1) was identified as a direct target of miR-374a. Silencing of SRCIN1 significantly enhanced cell proliferation, migration and invasion, whereas SRCIN1 reintroduction partially abrogated the oncogenic effects of miR-374a. Taken together, these findings suggest that miR-374a functions as a candidate oncogene in GC by directly targeting SRCIN1. miR-374a may therefore be useful as a promising therapeutic target for malignant GC.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tris(tert-butoxy)silanol, 99.999%
Sigma-Aldrich
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)